Late Conversion From Calcineurin Inhibitors to Belatacept in Kidney-Transplant Recipients Has a Significant Beneficial Impact on Glycemic Parameters

BACKGROUND. Calcineurin inhibitors (CNIs) and steroids are strongly associated with new-onset diabetes after transplantation, worsening of pre-existing diabetes, and cardiovascular events. We assessed the benefit of conversion from CNI-based to belatacept-based immunosuppression in diabetic kidney-t...

全面介紹

Na minha lista:
書目詳細資料
發表在:Transplant Direct
Main Authors: Terrec, Florian, Jouve, Thomas, Naciri-Bennani, Hamza, Benhamou, Pierre-Yves, Malvezzi, Paolo, Janbon, Benedicte, Giovannini, Diane, Rostaing, Lionel, Noble, Johan
格式: Artigo
語言:Inglês
出版: Wolters Kluwer Health 2019
主題:
Kidney Transplantation
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6964931/
https://ncbi.nlm.nih.gov/pubmed/32047845
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000000964
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍